AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Over the past month, shares of this drugmaker have returned +6.7%, compared to the Zacks S&P 500 composite's +3.5% change. During this period, the Zacks Large Cap Pharmaceuticals industry, which AbbVie falls in, has gained 8%. The key question now is: What could be the stock's future direction?While media releases or ...